| 中文名 | 2-氨基-6-甲基-4,5,6,7-四噻吩[2,3-C]吡啶-3-甲酸乙酯 |
|---|---|
| 英文名 | ethyl 2-amino-6-benzyl-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxylate |
| 中文别名 |
2-氨基-6-苯基-4,5,6,7-四氢噻吩[2,3-C]吡啶-3-羧酸乙酯
氨苄噻吡酯 替诺立定 噻嗯吡啶 2-氨基-6-苄基-4,5,6,7-四氢噻吩并[2,3-C]吡啶-3-羧酸乙酯 2-氨基-6-苄基-4,5,6,7-四氢噻吩乙酯[2,3-c]吡啶-3-羧酸乙酯 替诺立定,10 MM DMSO 溶液 |
| 英文别名 |
Tinoridine, 10 mM in DMSO
tinoridine 2-amino-3-aethoxycbonyl-6-benzyl-4,5,6,7-tetrahydrothieno(2,3-c)pyridin Dimaten Cholecalciferol Impurity 26 2-amino-3-ethoxycbonyl-6-benzyl-4,5,6,7-tetrahydrothieno(2,3-c)pyridine Thieno[2,3-c]pyridine-3-cboxylic acid, 2-amino-4,5,6,7-tetrahydro-6-(phenylMethyl)-, ethyl ester Ethyl 2-amino-6-benzyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-cboxylate Tinoridine //BP Nonflamin (free base) Thieno(2,3-c)pyridine-3-cboxylic acid, 2-amin ethyl 2-amino-6-(phenylmethyl)-5,7-dihydro-4H-thieno[5,4-c]pyridine-3-cboxylate Thieno(2,3-c)pyridine-3-cboxylic acid, 2-amino-4,5,6,7-tetrahydro-6-(phenylmethyl)-, ethyl ester (9CI) 3-c)pyridine-3-cboxylicacid,4,5,6,7-tetrahydro-2-amino-6-benzyl-thieno( 2-AMINO-3-ETHOXY-carbonyl-6-BENZYL-4,5,6,7-TETRAHYDROTHIEN 2-amino-6-(phenylmethyl)-5,7-dihydro-4H-thieno[5,4-c]pyridine-3-cboxylic acid ethyl ester 2-amino-6-(phenylmethyl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-6-ium-3-cboxylic acid ethyl ester ethyl 2-amino-6-benzyl-4H 2-amino-6-benzyl-4,5,6,7-tetrahydrothieno(2,3-c)pyridine-3-cboxylicacidet 2-Amino-6-benzyl-3-(ethoxycbonyl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine, Tinoridine ethyl 2-amino-6-benzyl-4H,5H,6H,7H-thieno[2,3-c]pyridine-3-cboxylate 2-Amino-6-benzyl-4,5,6,7-tetrahydro-thieno<pyridin-3-carbonsaeuereethylester 2-amino-6-(benzyl)-5,7-dihydro-4H-thieno[5,4-c]pyridine-3-cboxylic acid ethyl ester Y 3642 7H-thieno[2 y-3642 |
| 描述 | 替诺瑞定(Y-3642)是一种口服活性非甾体抗炎剂,具有较强的抗氧化能力和自由基清除剂活性。替诺瑞定通过抑制COX酶发挥作用,参与肝毒性抑制。[1][2][3]. |
|---|---|
| 相关类别 | |
| 体外研究 | 替诺瑞定(10-100μM)对大鼠肝脏和肾脏溶酶体以及肝实质细胞的稳定性有影响[3]。替诺瑞定(1、10和100μM;30分钟)抑制体外肝赖氨酸自发释放酸性磷酸酶[3]。 |
| 体内研究 | 替诺瑞定(100 mg/kg;口服;单剂量)可抑制大鼠的CCl4肝毒性,对CCl4诱导的酶活性有很强的控制作用[2]。替诺瑞定(100 mg/kg;i.p.;单剂量)在体内保护大鼠肝脏和肾脏溶酶体的稳定性[3]。动物模型:雄性Wistar大鼠(180-220 g)[2]剂量:100 mg/kg给药:口服灌胃;单剂量;结果:抑制了CCl4诱导的血清谷氨酸-草酰乙酸转氨酶和谷氨酸-丙酮酸转氨酶活性的升高,并挽救了肝微粒体细胞色素p-450和葡萄糖-6-磷酸酶活性。 |
| 密度 | 1.256 g/cm3 |
|---|---|
| 沸点 | 493.5ºC at 760 mmHg |
| 熔点 | 112-113ºC |
| 分子式 | C17H20N2O2S |
| 分子量 | 316.41800 |
| 精确质量 | 316.12500 |
| PSA | 83.80000 |
| LogP | 3.58440 |
| 蒸汽压 | 7E-10mmHg at 25°C |
| 储存条件 | 室温 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| 海关编码 | 2934999090 |
|---|
|
~92%
24237-54-5 |
| 文献:Meng, Shuangming; Jia, Zhifang; Wang, Kewei; Fan, Yueqin; Guo, Yong Synthetic Communications, 2014 , vol. 44, # 10 p. 1461 - 1465 |
| 海关编码 | 2934999090 |
|---|---|
| 中文概述 | 2934999090. 其他杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途 |
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |